Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

NCT05250037 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT05250037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
March 30, 2022
Completion date
December 31, 2028
Enrollment
261 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiolitis obliterans syndrome, hematopoietic and lymphoid cell neoplasm